Adaptin Bio, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Adaptin Bio, Inc. (APTN) had Deferred Tax Assets, Operating Loss Carryforwards of $1.67 million as of 2025-12-31, per its S-1 filed 2026-08-28.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-08-28
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $1.67M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $273.02K.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $81.33K.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $27.80K.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $1.67M S-1 · filed 2026-08-28 |
| 2024-12-31 | $273.02K S-1 · filed 2026-08-28 |
| 2023-12-31 | $81.33K 10-K · filed 2024-04-01 |
| 2022-12-31 | $27.80K 10-K · filed 2024-04-01 |